CLOSED STUDIES / Ovarian Cancer


GEICO 0703/MIMOSA


Title

Multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate maintenance treatment with abagovomab in patients suffering from epithelial ovarian carcinoma after complete response to first-line chemotherapy.


EudraCT

2006-002801-30


GEICO Coordinator

Dr. Antonio Casado


Patients Recruited

80 patients


Inclusion Closing Date

December of 2008